为婴幼儿便的微RNA分析优化协议
bioRxiv : the preprint server for biology
|April 16, 2025
概括
使用RNAlater或Zymo DNA/RNA Shield管与Zymo BIOMICs套件从婴儿便中获得了高质量的RNA和类似的microRNA档案. 这些发现支持使用婴儿便微RNA作为儿童发育和疾病的生物标志物的优化协议.
科学领域:
- 发现生物标志物的发现.
- 儿科研究的研究.
- 分子诊断学 分子诊断学
背景情况:
- 微RNAs (miRNAs) 显示为儿童发育和疾病的生物标志物具有前景.
- 婴儿和幼儿便越来越多地用于转录基因分析.
- 挑战包括便样本中的高RNase水平和丰富的微生物RNA.
研究的目的:
- 为了比较婴幼儿便的RNA保存和提取协议.
- 评估商业套件和RNA质量和miRNA分析的保存方法.
- 在儿科便样本中建立miRNA分析的优化协议.
主要方法:
- 第一个阶段:使用碎片分析对RNA质量进行三种RNA提取套件和四种保存方法的比较.
- 第二阶段:利用miRNA测序 (miRNA-seq) 来比较在RNAlater中保存的便中的miRNA配置文件与Zymo DNA/RNA Shield管.
- 生物信息分析包括读数的分类 (人与微生物) 和对准miRBase v22.1.2.
主要成果:
- 齐莫BIOMICs套件产生了最高的RNA质量号码 (RQN).
- RNAlater和Zymo DNA/RNA Shield管提供了可比较高质量的RNA产量.
- 两种保存方法之间没有观察到人类miRNA配置文件或检测到miRNA计数的显著差异.
结论:
- 在RNAlater或Zymo DNA/RNA Shield管中收集婴儿便,与Zymo BIOMICs套件相结合,产生高质量的RNA和一致的miRNA配置文件.
- 几种检测到的miRNAs (例如,miR-194a-3p,miR-200c-3p,miR-26a-5p) 都与肠道平衡有关.
- 这些发现为儿童便miRNA生物标志物研究的标准化方案提供了基础.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...


